Obesity Treatment and Prevention: New Directions
73rd Nestlé Nutrition Institute Workshop, Carlsbad, Calif., September 2011Editor(s): Drewnowski A. (Seattle, Wash.)
Rolls B.J. (University Park, Pa.)
New Directions for Prevention
Starting Early: Obesity Prevention during InfancyBirch L.L.a · Anzman-Frasca S.a · Paul I.M.b
aCenter for Childhood Obesity Research, Noll Laboratory, The Pennsylvania State University, University Park, PA, and bDepartment of Pediatrics, Milton S. Hershey Medical Center, Hershey, PA, USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Obesity prevalence among infants and young children has increased rapidly during the past 4 decades, a disturbing trend given early obesity’s association with later life obesity and its comorbidities. Fortunately, infancy is a period of great behavioral and metabolic plasticity offering numerous targets for preventive interventions. Modifiable factors that may affect early rapid weight gain and obesity risk include infant sleep duration, feeding to soothe infant distress, and the introduction of solid foods and transitional feeding. We discuss evidence linking these factors to weight outcomes, as well as results from behavioral obesity interventions in infancy, from our laboratory and others’. For example, in a recent pilot intervention, we focused on helping new mothers address three areas of infant behavior hypothesized to affect weight gain and early obesity risk: infant sleeping, crying, and feeding. First-time mothers were randomly assigned to receive either a Soothe/Sleep intervention, an Introduction of Solids intervention, both interventions, or no interventions. The interventions were delivered via home visits and showed positive effects on infant behaviors and weight outcomes at 1 year. Based on evidence from such pilot interventions, we assess the plausibility of targeting behavioral factors in infancy and suggest next steps for early prevention research.
© 2012 Nestec Ltd., Vevey/S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.